Company · CIK 1832038

# Invivyd, Inc.

| CIK | [1832038](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001832038) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | CT |
| Listed | IVVD (Nasdaq) |
| First annual or quarterly report | 2021-09-20 |

## Offerings

 4 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-290685 | Shelf Effective | 2025-10-02 | 2025-12-23 | 2 |
| 333-267643 | Shelf Effective | 2022-09-28 | 2025-11-19 | 7 |
| 333-276986 | Shelf Effective | 2024-02-09 | 2024-04-19 | 2 |
| 333-257975 | IPO Final prospectus | 2021-07-16 | 2021-08-06 | 5 |

## Filings

 17

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2025-12-23 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1832038/999999999525003900/9999999995-25-003900-index.htm) Declared effective | 333-290685 | 9999999995-25-003900 |
| 2025-11-19 | [424B5](https://www.sec.gov/Archives/edgar/data/1832038/000119312525286661/0001193125-25-286661-index.htm) Shelf takedown | 333-267643 | 0001193125-25-286661 |
| 2025-11-17 | [424B5](https://www.sec.gov/Archives/edgar/data/1832038/000119312525284616/0001193125-25-284616-index.htm) Shelf takedown | 333-267643 | 0001193125-25-284616 |
| 2025-10-02 | [S-3](https://www.sec.gov/Archives/edgar/data/1832038/000119312525228321/0001193125-25-228321-index.htm) Shelf registered | 333-290685 | 0001193125-25-228321 |
| 2025-08-22 | [424B5](https://www.sec.gov/Archives/edgar/data/1832038/000119312525185639/0001193125-25-185639-index.htm) Shelf takedown | 333-267643 | 0001193125-25-185639 |
| 2025-08-20 | [424B5](https://www.sec.gov/Archives/edgar/data/1832038/000119312525184075/0001193125-25-184075-index.htm) Shelf takedown | 333-267643 | 0001193125-25-184075 |
| 2024-04-19 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1832038/999999999524001044/9999999995-24-001044-index.htm) Declared effective | 333-276986 | 9999999995-24-001044 |
| 2024-02-09 | [S-3](https://www.sec.gov/Archives/edgar/data/1832038/000119312524030154/0001193125-24-030154-index.htm) Shelf registered | 333-276986 | 0001193125-24-030154 |
| 2023-12-22 | [424B5](https://www.sec.gov/Archives/edgar/data/1832038/000119312523302190/0001193125-23-302190-index.htm) Shelf takedown | 333-267643 | 0001193125-23-302190 |
| 2022-10-05 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1832038/999999999522002946/9999999995-22-002946-index.htm) Declared effective | 333-267643 | 9999999995-22-002946 |
| 2022-09-28 | [S-3](https://www.sec.gov/Archives/edgar/data/1832038/000119312522253372/0001193125-22-253372-index.htm) Shelf registered | 333-267643 | 0001193125-22-253372 |
| 2021-08-06 | [424B4](https://www.sec.gov/Archives/edgar/data/1832038/000119312521239375/0001193125-21-239375-index.htm) Final prospectus | 333-257975 | 0001193125-21-239375 |
| 2021-08-05 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1832038/999999999521003063/9999999995-21-003063-index.htm) Declared effective | 333-257975 | 9999999995-21-003063 |
| 2021-08-04 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1832038/000119312521236445/0001193125-21-236445-index.htm) Amendment | 333-257975 | 0001193125-21-236445 |
| 2021-08-02 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1832038/000119312521232137/0001193125-21-232137-index.htm) Amendment | 333-257975 | 0001193125-21-232137 |
| 2021-07-16 | [S-1](https://www.sec.gov/Archives/edgar/data/1832038/000119312521217506/0001193125-21-217506-index.htm) Registration filed | 333-257975 | 0001193125-21-217506 |
| 2021-05-21 | [DRS](https://www.sec.gov/Archives/edgar/data/1832038/000095012321007258/0000950123-21-007258-index.htm) Draft made public | 377-04916 | 0000950123-21-007258 |

[All filings of this company](https://equitycapital.markets/filings?cik=1832038) · [CSV](https://equitycapital.markets/filings.csv?cik=1832038)

---
Source page: https://equitycapital.markets/company/1832038 · Data: U.S. SEC EDGAR · CC BY 4.0